The purpose of this study is to determine whether giving ALT-803 (a cytokine interleukin-15 superagonist) will be safe and effective for treating cancer that has spread to the lungs.
Thank you for wanting to be a part of our clinical trials program. We greatly appreciate your desire to inform others about our trials, and/or refer cases to the Veterinary Medical Teaching Hospital (VMTH) at UC Davis. The VCCT and our clinical trials wouldn't be here without you!
For more news and updates, follow us on social media.